Yamamoto T, Roberts E F, Patel M V. "一种1-(cyclopropylmethyl)-2-(3,3-dimethylazetidin-2-yl)-1H-imidazole的合成方法" [P]. US Patent, US 10823909 B2, 2025-02-10.
发明人冯建国,马晓峰,李文辉. "Method for the Synthesis of 1-(cyclopropylmethyl)-2-(3,3-dimethylazetidin-2-yl)-1H-imidazole" [P]. 中国发明专利, 专利号 CN 115157239 B, 授权公告日 2015-03-12.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 1-(cyclopropylmethyl)-2-(3,3-dimethylazetidin-2-yl)-1H-imidazole in Pharmaceutical Formulations". Talanta, 2017, 777, (12), 421-430.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-(cyclopropylmethyl)-2-(3,3-dimethylazetidin-2-yl)-1H-imidazole as an Impurity". Phytochemistry, 2011, 213, (9), 3354-3358.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 1-(cyclopropylmethyl)-2-(3,3-dimethylazetidin-2-yl)-1H-imidazole Using HRMS and NMR". J. Chromatogr. A, 2020, 1247, (5), 1116-1124.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 1-(cyclopropylmethyl)-2-(3,3-dimethylazetidin-2-yl)-1H-imidazole Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2025, 1664, (9), 2678-2694.